DANIFEXOR
UNII TUU8G1CX9O

Substance Identification & Data

This profile provides standardized clinical and technical data for Danifexor, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TUU8G1CX9O.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2648738-68-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

TUU8G1CX9O

CAS Registry Number

2648738-68-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DANIFEXOR

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C29H20Cl2N2O5

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

CQQYMDWPAWAMPJ-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C215267

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

156455076

Unique identification number in the NCBI database of chemical substances.

INN ID

13339

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1(c2onc(-c3c(Cl)cccc3Cl)c2COc4ccc5cc(Oc6ncc(C(=O)O)cc6)ccc5c4)CC1

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Danifexor. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.